Sign in / Join Now
ETFs & Funds
at $40 looks very attractive.
Getting killed on this position. 3-for-2 split into hell. Looks like market wants to value this as a pharma. Need an exit at 55. Maybe 2019.
Add a reply...
Latest StockTalks »
people get INSY breaking news and analysis by email alert.
Get email alerts on INSY »
Insys Therapeutics, Inc.
Get latest price
From other sites
Insys Therapeutics Announces CEO Succession Plan
at TheStreet (Wed, 7:00AM)
What Makes INSYS Therapeutics (INSY) a Strong Sell?
at Zacks.com (Sep 6, 2016)
Insys Therapeutics, Inc. To Present At Morgan Stanley Global Healthcare Conference
at TheStreet (Sep 1, 2016)
Purcell Julie & Lefkowitz LLP Is Investigating Insys Therapeutics, Inc. For Potential Breaches Of Fiduciary Duty By Its Board Of Directors
at TheStreet (Aug 30, 2016)
Insys Therapeutics Reports Phase 3 Trial Of Sublingual Buprenorphine Spray Met Primary Endpoint In Patients With Moderate-to-Severe Postoperative Pain After Bunionectomy
at TheStreet (Aug 24, 2016)